Literature DB >> 20636924

Pets-related peritonitis in peritoneal dialysis: companion animals or trojan horses?

Ashley Broughton1, Christian Verger, Eric Goffin.   

Abstract

Infectious peritonitis is still a major concern in peritoneal dialysis (PD). Standard antibiotic regimens target common causative microorganisms such as Staphylococcus aureus and epidermidis or Pseudomonas aeruginosa. When the infection does not respond, unusual infective agents are to be considered including zoonoses-infections with an animal source. Companion animals or occupations involving animal contact favor the development of zoonoses, especially for immunocompromised patients such as those with end-stage renal disease. We reviewed the literature for all animals-related peritonitis in PD and analyzed data from our own PD unit and from the French-speaking registry for peritoneal dialyis (RDPLF) to assess both the frequency and the potential risk for PD patients in owning a pet or to working with animals. In a literature search, we identified 124 cases of PD peritonitis caused by 12 different zoonotic agents. Animals were involved in 24% of the cases. Overall mortality rate was 13.5% and Tenckhoff catheters had to be removed in 27% of the cases. The results from RDPLF analysis show that zoonotic microorganisms were responsible for 0.54% of the peritonitis episodes (51 out of a total of 9433 during a 9-year period). In our unit, zoonotic microorganisms were responsible for 0.03% of the peritonitis episodes (four out of a total of 128 during a 9-year period). Considering those results, some specific treatment recommendations can be made, but the major factor still remains prevention, by insisting on strict hygenic measures when a PD patient owns a pet.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20636924     DOI: 10.1111/j.1525-139X.2010.00726.x

Source DB:  PubMed          Journal:  Semin Dial        ISSN: 0894-0959            Impact factor:   3.455


  8 in total

Review 1.  Peritoneal dialysis-related infections recommendations: 2016 update. What is new?

Authors:  Vassilios Liakopoulos; Olga Nikitidou; Theofanis Kalathas; Stefanos Roumeliotis; Marios Salmas; Theodoros Eleftheriadis
Journal:  Int Urol Nephrol       Date:  2017-06-01       Impact factor: 2.370

2.  Staphylococcus lentus peritonitis: a case report.

Authors:  Maite Rivera; Martha Diaz Dominguez; Nuria Rodriguez Mendiola; Gloria Ruiz Roso; Carlos Quereda
Journal:  Perit Dial Int       Date:  2014-06       Impact factor: 1.756

3.  Pet-related peritonitis and its prevention in peritoneal dialysis: a case study.

Authors:  Mekdess Abebe; Cheryl Laveglia; Sunil George; Nand K Wadhwa
Journal:  Perit Dial Int       Date:  2014-06       Impact factor: 1.756

Review 4.  Difficult peritonitis cases in children undergoing chronic peritoneal dialysis: relapsing, repeat, recurrent and zoonotic episodes.

Authors:  Sevcan A Bakkaloglu; Bradley A Warady
Journal:  Pediatr Nephrol       Date:  2014-09-18       Impact factor: 3.714

5.  Pharmacokinetics and Pharmacodynamics of Fungal Defensin NZX Against Staphylococcus aureus-Induced Mouse Peritonitis Model.

Authors:  Xueling Zheng; Na Yang; Ruoyu Mao; Ya Hao; Da Teng; Jianhua Wang
Journal:  Front Microbiol       Date:  2022-06-01       Impact factor: 6.064

Review 6.  Reducing peritoneal dialysis-related peritonitis rate.

Authors:  Anupkumar Shetty
Journal:  Ochsner J       Date:  2014

Review 7.  ISPD Peritonitis Recommendations: 2016 Update on Prevention and Treatment.

Authors:  Philip Kam-Tao Li; Cheuk Chun Szeto; Beth Piraino; Javier de Arteaga; Stanley Fan; Ana E Figueiredo; Douglas N Fish; Eric Goffin; Yong-Lim Kim; William Salzer; Dirk G Struijk; Isaac Teitelbaum; David W Johnson
Journal:  Perit Dial Int       Date:  2016-06-09       Impact factor: 1.756

8.  Peritonitis Secondary to Uncommon Gram-Negative Coccobacillus Transmitted From a Cat in a Patient on Peritoneal Dialysis.

Authors:  Sreedhar Adapa; Srikanth Naramala; Bhaskar Reddy Madhira; Vijay Gayam; Prem Sahasranam; Venu Madhav Konala
Journal:  J Investig Med High Impact Case Rep       Date:  2019 Jan-Dec
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.